Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.
This study examined the use of affinity microcolumns as tools for the rapid analysis and high-throughput screening of drug-protein binding. The protein used was immobilized human serum albumin (HSA) and the model analytes were warfarin and L-tryptophan, two solutes often used as site-specific probes for drug binding to Sudlow sites I and II of HSA, respectively. The use of HSA microcolumns in binding studies was examined by using both zonal elution and frontal analysis formats. The zonal elution studies were conducted by injecting the probe compounds onto HSA microcolumns of varying lengths while measuring the resulting retention factors, plate heights and peak asymmetries. A decrease in the retention factor was noted when moving from longer to shorter column lengths while using a constant amount of injected solute. However, this change could be corrected, in part, by determining the relative retention factor of a solute versus a reference compound injected onto the same microcolumn. The plate height values were relatively consistent for all column lengths and gave an expected increase at higher linear velocities. The peak asymmetries were similar for all columns up to 1 mL/min but shifted to larger values at higher flow rates and when using short microcolumns (e.g., 1 mm length). The association equilibrium constants and number of binding sites estimated by frontal analysis for warfarin with HSA were consistent at the various column sizes that were tested and gave good agreement with previous literature values. These results confirmed affinity microcolumns provide comparable results to those obtained with longer columns and can be used in the rapid analysis of drug-protein binding and in the high-throughput screening of such interactions.
Yoo
Michelle J
MJ
Department of Chemistry, University of Nebraska-Lincoln, 704 Hamilton Hall, Lincoln, NE 68588-0304, USA.
Schiel
John E
JE
Hage
David S
DS
D002846:Chromatography, Affinity / Q000379:methods*; D006801:Humans; D007700:Kinetics; D004364:Pharmaceutical Preparations / Q000737:chemistry; D011485:Protein Binding; D012709:Serum Albumin / Q000737:chemistry*; D014364:Tryptophan / Q000737:chemistry*; D014859:Warfarin / Q000737:chemistry*
D004364:Pharmaceutical Preparations; D012709:Serum Albumin; D014859:Warfarin; D014364:Tryptophan
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):83-91
16621742
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 25;809(1):137-45
15282104
Drug Metab Pharmacokinet. 2005 Oct;20(5):309-23
16272748
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):138-46
16687257
J Chromatogr B Biomed Sci Appl. 2000 Feb 28;739(1):39-54
10744312
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):22-6
18554995
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):3-30
11939555
Anal Chem. 1994 Nov 1;66(21):3814-22
7802261
Anal Biochem. 1985 Oct;150(1):76-85
3843705
Methods Enzymol. 1984;104:212-23
6371445
Anal Biochem. 2003 Aug 1;319(1):1-12
12842101
J Sep Sci. 2009 Aug;32(15-16):2776-85
19630007
J Sep Sci. 2009 Apr;32(8):1145-55
19296478
J Chromatogr. 1979 Nov 28;180(1):103-10
541445
J Chromatogr A. 1994 May 27;669(1-2):9-19
8055106
Comb Chem High Throughput Screen. 2002 Aug;5(5):395-406
12180905
J Chromatogr A. 1997 Apr 4;766(1-2):15-25
9134727
J Sep Sci. 2009 Mar;32(5-6):835-53
19278006
Anal Chem. 2004 Dec 1;76(23):440A-448A
15595185
J Chromatogr A. 2009 Apr 17;1216(16):3492-500
18926542
Pharmacol Rev. 1981 Mar;33(1):17-53
7027277
Mol Pharmacol. 1976 Nov;12(6):1052-61
1004490
J Chromatogr. 1993 Aug 20;645(2):241-50
8408417
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 1;876(1):69-75
18980867
Anal Chem. 2006 Apr 15;78(8):2672-83
16615779
Curr Med Chem. 2002 Aug;9(15):1463-81
12173977
J Pharm Biomed Anal. 2006 Jun 16;41(4):1101-9
16545534
J Chromatogr A. 2009 May 1;1216(18):3794-801
19272606
J Chromatogr. 1992 Jun 10;577(2):305-15
1400761
J Chromatogr. 1992 Sep 2;579(2):225-35
1429970